CTKB – cytek biosciences, inc. (US:NASDAQ)
Stock Stats
News
Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
Cytek Biosciences, Inc. (NASDAQ: CTKB) had its price target raised by analysts at Piper Sandler from $8.00 to $8.50. They now have an "overweight" rating on the stock.
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
Cytek Biosciences Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: Busque Philippe
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: Barnett Valerie
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: Jiang Wenbin
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: Poirson Allen
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: Yan Ming
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.